Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.6M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
17.9M
-
Shares change
-
+17.9M
-
Total reported value, excl. options
-
$125M
-
Value change
-
+$125M
-
Number of buys
-
45
-
Price
-
$7.03
Significant Holders of Vigil Neuroscience, Inc. - Common Stock (VIGL) as of Q1 2022
46 filings reported holding VIGL - Vigil Neuroscience, Inc. - Common Stock as of Q1 2022.
Vigil Neuroscience, Inc. - Common Stock (VIGL) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.9M shares
of 46.6M outstanding shares and own 38.3% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (5.84M shares), Northpond Ventures, LLC (4.21M shares), CITADEL ADVISORS LLC (2.16M shares), Artal Group S.A. (1.12M shares), Cormorant Asset Management, LP (617K shares), Pivotal bioVenture Partners Investment Advisor LLC (561K shares), Rock Springs Capital Management LP (472K shares), ORBIMED ADVISORS LLC (411K shares), Deep Track Capital, LP (389K shares), and VANGUARD GROUP INC (385K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.